1. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study
- Author
-
Fereidoun Azizi, Maryam Rahmati, Fahimeh Ramezani Tehrani, Fatemeh Mahboobifard, Amir Abbas Momenan, Ehsan Rojhani, and Atrin Niknam
- Subjects
Male ,medicine.medical_specialty ,endocrine system diseases ,Coronary Artery Disease ,Disease ,Iran ,Cohort Studies ,Coronary artery disease ,Population based cohort ,Internal medicine ,medicine ,Humans ,Endocrine system ,cardiovascular diseases ,business.industry ,Incidence (epidemiology) ,Hazard ratio ,Confounding ,General Medicine ,medicine.disease ,Polycystic ovary ,female genital diseases and pregnancy complications ,Cardiovascular Diseases ,Female ,business ,Polycystic Ovary Syndrome - Abstract
Background The existing data regarding the impact of Polycystic Ovary Syndrome (PCOS) on the risk of developing cardiovascular disease (CVD) are conflicting. Aim To explore the effect of PCOS status on the occurrence of silent coronary artery disease (CAD)/CVD. Methods A total of 1591 women without CVD at baseline, aged 18–45 years, including 356 PCOS patients (defined by the Rotterdam criteria) and 1235 eumenorrheic non-hirsute women without polycystic ovarian morphology (controls), were selected from the Tehran Lipid and Glucose Study (TLGS). The median follow-up was 15.4 years, and most participants were in their late reproductive years at the end of the study. Silent CAD and CVD outcomes in PCOS and control groups were compared according to the multivariable-adjusted hazard ratios (HRs) and cumulative hazard functions. Results There was no difference in CVD risk factors between the PCOS and control groups. After controlling for confounders, PCOS status did not increase the risk of silent CAD (HR: 0.96, 95% CI 0.86–1.08). Regardless of PCOS status, women with a history of silent CAD showed 2.25 times higher CVD events than those without this history (95% CI 1.63–3.10). PCOS status reduced the CVD incidence by 42%, independently of silent CAD or traditional risk factors (HR: 0.58, 95% CI 0.35–0.98). Conclusions Whereas silent CAD, regardless of PCOS, accelerated CVD, PCOS preserved it, most likely due to a combination of protective factors, including the endocrine pattern in the late reproductive period, environmental/social elements, and recruiting additional counseling and lifestyle modifications.
- Published
- 2022
- Full Text
- View/download PDF